Citing new data, Pfizer outlined a case for booster shots, but there’s a debate over whether they’re needed.

BY CARL ZIMMER, APOORVA MANDAVILLI, SHARON LAFRANIERE AND REBECCA ROBBINS | NYTimes Health | Disclosure